Determination of Seminal Concentration of Fingolimod and Fingolimod-Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod-Reference-Cited by-同舟云学术

Determination of Seminal Concentration of Fingolimod and Fingolimod-Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod

Published:2017-12-19 Issue:2 Volume:7 Page:217-221
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

David Olivier J.¹,Berwick Amy²,Pezous Nicole¹,Lang Michael³,Tiel-Wilck Klaus⁴,Ziemssen Tjalf⁵,Li Peng⁶,Hara Hisanori¹,Schmouder Robert⁷

Affiliation:

1. Novartis Pharma AG; Basel Switzerland

2. Novartis Institutes for Biomedical Research; Cambridge MA USA

3. NeuroPoint, Ulm and NTD Study Group; Ulm Germany

4. Neurologisches Facharztzentrum, NTD Study Group; Berlin Germany

5. Technische Universität; Dresden Germany

6. WuXi AppTec Co; Shanghai China

7. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

Funder

Novartis Pharma AG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference15 articles.

1. The transport of chemicals in semen;Klemmt;Birth Defects Res B Dev Reprod Toxicol,2005

2. Drugs in semen;Pichini;Clin Pharmacokinet,1994

3. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis;Brinkmann;Nat Rev Drug Discov,2010

4. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis;Mehling;Neurology,2008

5. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N Engl J Med,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy;Clinical and Translational Neuroscience;2024-08-01

2. Liquid chromatography–tandem mass spectrometry for determination of fingolimod and its active metabolite fingolimod phosphate in whole blood of patients with multiple sclerosis;Biomedical Chromatography;2024-06-26

3. Determination of Fingolimod and its Metabolite Fingolimod‐Phosphate in Human Blood by Tandem Mass Spectrometry; Application to Bioequivalence Study;2024

4. Lessons from S1P receptor targeting in multiple sclerosis;Pharmacology & Therapeutics;2022-02

5. Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration;Frontiers in Immunology;2020-04-08